The Trendlines Group (SGX:42T) said its board and audit committee approved investments by related companies of Librae Holdings in its portfolio firms, according to a Friday filing on the Singapore Exchange.
The Librae-related companies, ultimately owned by a trust benefiting British businessman Vincent Tchenguiz, will invest a total of $2.2 million across four Trendlines-backed firms, while Trendlines itself will contribute $850,000.
Trendlines said the investments include $350,000 in Arcuro Medical, $600,000 in IBI AG, $600,000 in Ceretrieve, and $600,000 in Celleste Bio.
The funding will be structured as either share purchase agreements or Simple Agreements for Future Equity (SAFE).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.